T2 Biosystems (TTOO) Set to Announce Quarterly Earnings on Monday

T2 Biosystems (NASDAQ:TTOO) will post its quarterly earnings results after the market closes on Monday, July 29th. T2 Biosystems has set its FY 2024 guidance at EPS.

T2 Biosystems (NASDAQ:TTOO) last released its quarterly earnings results on Monday, May 6th. The medical equipment provider reported ($2.66) earnings per share for the quarter. The business had revenue of $2.06 million for the quarter.

T2 Biosystems Stock Down 3.7 %

TTOO traded down $0.19 during trading on Tuesday, hitting $4.91. The company’s stock had a trading volume of 3,213 shares, compared to its average volume of 277,677. T2 Biosystems has a one year low of $2.60 and a one year high of $70.00. The business’s 50 day simple moving average is $5.19 and its 200-day simple moving average is $4.48.

Analyst Ratings Changes

Separately, Canaccord Genuity Group decreased their price target on shares of T2 Biosystems from $12.00 to $3.00 and set a “hold” rating on the stock in a research report on Monday, April 29th.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.